Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S5 from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window
  1. Home
  2. Publications
  3. Supplementary Figure S5 from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window

Supplementary Figure S5 from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window

Authors:
  • TSTero Satomaa
    Tero Satomaa
  • HPHenna Pynnönen
    Henna Pynnönen
  • OAOlli Aitio
    Olli Aitio
  • JHJukka O. Hiltunen
    Jukka O. Hiltunen
  • VPVirve Pitkänen
    Virve Pitkänen
  • TLTuula Lähteenmäki
    Tuula Lähteenmäki
  • TKTitta Kotiranta
    Titta Kotiranta
  • AHAnnamari Heiskanen
    Annamari Heiskanen
  • AHAnna-Liisa Hänninen
    Anna-Liisa Hänninen
  • RNRitva Niemelä
    Ritva Niemelä
  • JHJari Helin
    Jari Helin
  • HKHeikki Kuusanmäki
    Heikki Kuusanmäki

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.32711923
Abstract
Characterization of overconjugated GLK-33 batch in rat tolerability and toxicokinetic study.
Keywords
  • ACUTE MYELOID
  • AURISTATIN CONJUGATE
  • SUPPLEMENTARY FIGURE
  • MYELOID LEUKEMIA
  • WIDE THERAPEUTIC
  • THERAPEUTIC WINDOW
  • WINDOW CHARACTERIZATION
  • TOXICOKINETIC STUDY
  • RAT TOLERABILITY
  • FIGURE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.